核医学の世界市場2015-2022...市場調査レポートについてご紹介

【英文タイトル】Nuclear Medicine - Global Market Outlook (2015-2022)

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Nuclear Medicine Market, By Application
5.1 Introduction
5.2 Therapeutics
5.2.1 Bone Metastasis
5.2.2 Endocrine Tumors
5.2.3 Lymphoma
5.2.4 Thyroid
5.2.5 Nephrology
5.2.6 Cardiology
5.2.7 Neurology
5.2.8 Other Therapeutic Applications
5.3 Diagnostics
5.3.1 Positron Emission Tomography (PET)
5.3.1.1 Oncology
5.3.1.2 Neurology
5.3.1.3 Cardiology
5.3.1.4 Inflammation
5.3.1.5 Other PET Applications
5.3.2 Single Photon Emission Computed Tomography (SPECT)
5.3.2.1 Thyroid
5.3.2.2 Neurology
5.3.2.3 Lymphoma
5.3.2.4 Cardiology
5.3.2.5 Gastro Intestinal
5.3.2.6 Oncology
5.3.2.7 Nephrology
5.3.2.8 Inflammation
5.3.2.5 Other Diagnostic Applications

6 Global Nuclear Medicine Market, By Type
6.1 Introduction
6.2 Nuclear Medicine Therapeutic Isotopes
6.2.1 Alpha Emitters
6.2.1.1 Thorium-227 (Th-227)
6.2.1.2 Radium-224
6.2.1.3 Radium-223
6.2.1.4 Lead (Pb-212)/Bismuth (Bi-212)
6.2.1.5 Astatine (At-211)
6.2.1.6 Actinium (Ac-225)
6.2.1.7 Others
6.2.2 Brachytherapy
6.2.2.1 Palladium-103
6.2.2.2 Iridium-192
6.2.2.3 Iodine-125
6.2.2.4 Cesium-131
6.2.2.5 Others
6.2.3 Beta Emitters
6.2.3.1 Yttrium-90 (Y-90)
6.2.3.2 Samarium-153 (SM-153)
6.2.3.3 Rhenium-186 (Re-186)
6.2.3.4 Lutetium-177 (Lu-177)
6.2.3.5 Iodine-131 (I-131)
6.2.3.6 Erbium (Er-169)
6.2.3.7 Strontium (Sr-89)
6.2.3.8 Others
6.3 Nuclear Medicine/Radiopharmaceuticals Diagnostics
6.3.1 Positron Emission Tomography (PET) Radiopharmaceuticals
6.3.1.1 Rubidium-82 (RB-82)
6.3.1.2 Fluorodeoxyglucose (FDG)
6.3.1.3 Gallium (Ga-68)
6.3.1.4 Others
6.3.2 Single Photon Emission Computed Tomography (SPECT)
6.3.2.1 Technetium-99m (TC-99m)
6.3.2.2 Thallium-201 (TL-201)
6.3.2.3 Gallium-67 (GA-67)
6.3.2.4 Iodine (I-123)
6.3.2.5 Samarium
6.3.2.6 Yttrium
6.3.2.7 Rhenium
6.3.2.8 Others

7 Global Nuclear Medicine Market, By Procedural Volume
7.1 Introduction
7.2 Therapeutic
7.2.1 Alpha Emitters
7.2.2 Beta Emitters
7.2.3 Brachytherapy
7.3 Diagnostics
7.3.1 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
7.3.2 Positron Emission Tomography (PET) Radiopharmaceuticals

8 Global Nuclear Medicine Market, By End User
8.1 Introduction
8.2 Academic Research Laboratories
8.3 Industries
8.4 Medical
8.4.1 Hospitals
8.4.2 Diagnostic Centers

9 Global Nuclear Medicine Market, By Stable Isotope
9.1 Introduction
9.2 Sulphur (S-32)
9.3 Oxygen (O-18)
9.4 Nitrogen (N-15)
9.5 Deuterium (D2)
9.6 Carbon (C-13)
9.7 Other Stable Isotopes

10 Global Nuclear Medicine Market, By Geography
10.1 North America
10.1.1 US
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 UK
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia Pacific
10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 Australia
10.3.5 New Zealand
10.3.6 Rest of Asia Pacific
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Brazil
10.4.3 Argentina
10.4.4 South Africa
10.4.5 Egypt

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Advanced Accelerator Applications S.A.
12.2 Ashby Gorman Baker Ltd,
12.3 Bayer Healthcare
12.4 Bracco Imaging S.P.A
12.5 Cardinal Health
12.6 Digirad
12.7 Eczcibasi-Monrol Nuclear Products
12.8 GE Healthcare
12.9 IBA Molecular Imaging
12.10 Lantheus Medical Imaging
12.11 Mallinckrodt PLC
12.12 Mediso Ltd.
12.13 Nordion, Inc.
12.14 Philips Healthcare
12.15 Siemens Healthcare

Table of Contents
1 Global Nuclear Medicine Market Outlook, By Region (2013-2022) ($MN)
2 Global Nuclear Medicine Market Outlook, By Application (2013-2022) ($MN)
3 Global Nuclear Medicine Market Outlook, By Therapeutics (2013-2022) ($MN)
4 Global Nuclear Medicine Market Outlook, By Bone Metastasis (2013-2022) ($MN)
5 Global Nuclear Medicine Market Outlook, By Endocrine Tumors (2013-2022) ($MN)
6 Global Nuclear Medicine Market Outlook, By Lymphoma (2013-2022) ($MN)
7 Global Nuclear Medicine Market Outlook, By Thyroid (2013-2022) ($MN)
8 Global Nuclear Medicine Market Outlook, By Nephrology (2013-2022) ($MN)
9 Global Nuclear Medicine Market Outlook, By Cardiology (2013-2022) ($MN)
10 Global Nuclear Medicine Market Outlook, By Neurology (2013-2022) ($MN)
11 Global Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
12 Global Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
13 Global Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
14 Global Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
15 Global Nuclear Medicine Market Outlook, By Type (2013-2022) ($MN)
16 Global Nuclear Medicine Market Outlook, By Nuclear Medicine Therapeutic Isotopes (2013-2022) ($MN)
17 Global Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
18 Global Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
19 Global Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
20 Global Nuclear Medicine Market Outlook, By Nuclear Medicine/Radiopharmaceuticals Diagnostics (2013-2022) ($MN)
21 Global Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
22 Global Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
23 Global Nuclear Medicine Market Outlook, By Procedural Volume (2013-2022) ($MN)
24 Global Nuclear Medicine Market Outlook, By Therapeutic (2013-2022) ($MN)
25 Global Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
26 Global Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
27 Global Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
28 Global Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
29 Global Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2013-2022) ($MN)
30 Global Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
31 Global Nuclear Medicine Market Outlook, By End User (2013-2022) ($MN)
32 Global Nuclear Medicine Market Outlook, By Academic Research Laboratories (2013-2022) ($MN)
33 Global Nuclear Medicine Market Outlook, By Industries (2013-2022) ($MN)
34 Global Nuclear Medicine Market Outlook, By Medical (2013-2022) ($MN)
35 Global Nuclear Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
36 Global Nuclear Medicine Market Outlook, By Diagnostic Centers (2013-2022) ($MN)
37 Global Nuclear Medicine Market Outlook, By Stable Isotope (2013-2022) ($MN)
38 Global Nuclear Medicine Market Outlook, By Sulphur (S-32) (2013-2022) ($MN)
39 Global Nuclear Medicine Market Outlook, By Oxygen (O-18) (2013-2022) ($MN)
40 Global Nuclear Medicine Market Outlook, By Nitrogen (N-15) (2013-2022) ($MN)
41 Global Nuclear Medicine Market Outlook, By Deuterium (D2) (2013-2022) ($MN)
42 Global Nuclear Medicine Market Outlook, By Carbon (C-13) (2013-2022) ($MN)
43 Global Nuclear Medicine Market Outlook, By Other stable isotopes (2013-2022) ($MN)
44 North America Nuclear Medicine Market Outlook, By Country (2013-2022) ($MN)
45 North America Nuclear Medicine Market Outlook, By Application (2013-2022) ($MN)
46 North America Nuclear Medicine Market Outlook, By Therapeutics (2013-2022) ($MN)
47 North America Nuclear Medicine Market Outlook, By Bone Metastasis (2013-2022) ($MN)
48 North America Nuclear Medicine Market Outlook, By Endocrine Tumors (2013-2022) ($MN)
49 North America Nuclear Medicine Market Outlook, By Lymphoma (2013-2022) ($MN)
50 North America Nuclear Medicine Market Outlook, By Thyroid (2013-2022) ($MN)
51 North America Nuclear Medicine Market Outlook, By Nephrology (2013-2022) ($MN)
52 North America Nuclear Medicine Market Outlook, By Cardiology (2013-2022) ($MN)
53 North America Nuclear Medicine Market Outlook, By Neurology (2013-2022) ($MN)
54 North America Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
55 North America Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
56 North America Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
57 North America Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
58 North America Nuclear Medicine Market Outlook, By Type (2013-2022) ($MN)
59 North America Nuclear Medicine Market Outlook, By Nuclear Medicine Therapeutic Isotopes (2013-2022) ($MN)
60 North America Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
61 North America Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
62 North America Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
63 North America Nuclear Medicine Market Outlook, By Nuclear Medicine/Radiopharmaceuticals Diagnostics (2013-2022) ($MN)
64 North America Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
65 North America Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
66 North America Nuclear Medicine Market Outlook, By Procedural Volume (2013-2022) ($MN)
67 North America Nuclear Medicine Market Outlook, By Therapeutic (2013-2022) ($MN)
68 North America Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
69 North America Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
70 North America Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
71 North America Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
72 North America Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2013-2022) ($MN)
73 North America Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
74 North America Nuclear Medicine Market Outlook, By End User (2013-2022) ($MN)
75 North America Nuclear Medicine Market Outlook, By Academic Research Laboratories (2013-2022) ($MN)
76 North America Nuclear Medicine Market Outlook, By Industries (2013-2022) ($MN)
77 North America Nuclear Medicine Market Outlook, By Medical (2013-2022) ($MN)
78 North America Nuclear Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
79 North America Nuclear Medicine Market Outlook, By Diagnostic Centers (2013-2022) ($MN)
80 North America Nuclear Medicine Market Outlook, By Stable Isotope (2013-2022) ($MN)
81 North America Nuclear Medicine Market Outlook, By Sulphur (S-32) (2013-2022) ($MN)
82 North America Nuclear Medicine Market Outlook, By Oxygen (O-18) (2013-2022) ($MN)
83 North America Nuclear Medicine Market Outlook, By Nitrogen (N-15) (2013-2022) ($MN)
84 North America Nuclear Medicine Market Outlook, By Deuterium (D2) (2013-2022) ($MN)
85 North America Nuclear Medicine Market Outlook, By Carbon (C-13) (2013-2022) ($MN)
86 North America Nuclear Medicine Market Outlook, By Other stable isotopes (2013-2022) ($MN)
87 Europe Nuclear Medicine Market Outlook, By Country (2013-2022) ($MN)
88 Europe Nuclear Medicine Market Outlook, By Application (2013-2022) ($MN)
89 Europe Nuclear Medicine Market Outlook, By Therapeutics (2013-2022) ($MN)
90 Europe Nuclear Medicine Market Outlook, By Bone Metastasis (2013-2022) ($MN)
91 Europe Nuclear Medicine Market Outlook, By Endocrine Tumors (2013-2022) ($MN)
92 Europe Nuclear Medicine Market Outlook, By Lymphoma (2013-2022) ($MN)
93 Europe Nuclear Medicine Market Outlook, By Thyroid (2013-2022) ($MN)
94 Europe Nuclear Medicine Market Outlook, By Nephrology (2013-2022) ($MN)
95 Europe Nuclear Medicine Market Outlook, By Cardiology (2013-2022) ($MN)
96 Europe Nuclear Medicine Market Outlook, By Neurology (2013-2022) ($MN)
97 Europe Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
98 Europe Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
99 Europe Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
100 Europe Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
101 Europe Nuclear Medicine Market Outlook, By Type (2013-2022) ($MN)
102 Europe Nuclear Medicine Market Outlook, By Nuclear Medicine Therapeutic Isotopes (2013-2022) ($MN)
103 Europe Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
104 Europe Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
105 Europe Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
106 Europe Nuclear Medicine Market Outlook, By Nuclear Medicine/Radiopharmaceuticals Diagnostics (2013-2022) ($MN)
107 Europe Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
108 Europe Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
109 Europe Nuclear Medicine Market Outlook, By Procedural Volume (2013-2022) ($MN)
110 Europe Nuclear Medicine Market Outlook, By Therapeutic (2013-2022) ($MN)
111 Europe Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
112 Europe Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
113 Europe Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
114 Europe Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
115 Europe Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2013-2022) ($MN)
116 Europe Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
117 Europe Nuclear Medicine Market Outlook, By End User (2013-2022) ($MN)
118 Europe Nuclear Medicine Market Outlook, By Academic Research Laboratories (2013-2022) ($MN)
119 Europe Nuclear Medicine Market Outlook, By Industries (2013-2022) ($MN)
120 Europe Nuclear Medicine Market Outlook, By Medical (2013-2022) ($MN)
121 Europe Nuclear Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
122 Europe Nuclear Medicine Market Outlook, By Diagnostic Centers (2013-2022) ($MN)
123 Europe Nuclear Medicine Market Outlook, By Stable Isotope (2013-2022) ($MN)
124 Europe Nuclear Medicine Market Outlook, By Sulphur (S-32) (2013-2022) ($MN)
125 Europe Nuclear Medicine Market Outlook, By Oxygen (O-18) (2013-2022) ($MN)
126 Europe Nuclear Medicine Market Outlook, By Nitrogen (N-15) (2013-2022) ($MN)
127 Europe Nuclear Medicine Market Outlook, By Deuterium (D2) (2013-2022) ($MN)
128 Europe Nuclear Medicine Market Outlook, By Carbon (C-13) (2013-2022) ($MN)
129 Europe Nuclear Medicine Market Outlook, By Other stable isotopes (2013-2022) ($MN)
130 Asia Pacific Nuclear Medicine Market Outlook, By Country (2013-2022) ($MN)
131 Asia Pacific Nuclear Medicine Market Outlook, By Application (2013-2022) ($MN)
132 Asia Pacific Nuclear Medicine Market Outlook, By Therapeutics (2013-2022) ($MN)
133 Asia Pacific Nuclear Medicine Market Outlook, By Bone Metastasis (2013-2022) ($MN)
134 Asia Pacific Nuclear Medicine Market Outlook, By Endocrine Tumors (2013-2022) ($MN)
135 Asia Pacific Nuclear Medicine Market Outlook, By Lymphoma (2013-2022) ($MN)
136 Asia Pacific Nuclear Medicine Market Outlook, By Thyroid (2013-2022) ($MN)
137 Asia Pacific Nuclear Medicine Market Outlook, By Nephrology (2013-2022) ($MN)
138 Asia Pacific Nuclear Medicine Market Outlook, By Cardiology (2013-2022) ($MN)
139 Asia Pacific Nuclear Medicine Market Outlook, By Neurology (2013-2022) ($MN)
140 Asia Pacific Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
141 Asia Pacific Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
142 Asia Pacific Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
143 Asia Pacific Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
144 Asia Pacific Nuclear Medicine Market Outlook, By Type (2013-2022) ($MN)
145 Asia Pacific Nuclear Medicine Market Outlook, By Nuclear Medicine Therapeutic Isotopes (2013-2022) ($MN)
146 Asia Pacific Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
147 Asia Pacific Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
148 Asia Pacific Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
149 Asia Pacific Nuclear Medicine Market Outlook, By Nuclear Medicine/Radiopharmaceuticals Diagnostics (2013-2022) ($MN)
150 Asia Pacific Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
151 Asia Pacific Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
152 Asia Pacific Nuclear Medicine Market Outlook, By Procedural Volume (2013-2022) ($MN)
153 Asia Pacific Nuclear Medicine Market Outlook, By Therapeutic (2013-2022) ($MN)
154 Asia Pacific Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
155 Asia Pacific Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
156 Asia Pacific Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
157 Asia Pacific Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
158 Asia Pacific Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2013-2022) ($MN)
159 Asia Pacific Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
160 Asia Pacific Nuclear Medicine Market Outlook, By End User (2013-2022) ($MN)
161 Asia Pacific Nuclear Medicine Market Outlook, By Academic Research Laboratories (2013-2022) ($MN)
162 Asia Pacific Nuclear Medicine Market Outlook, By Industries (2013-2022) ($MN)
163 Asia Pacific Nuclear Medicine Market Outlook, By Medical (2013-2022) ($MN)
164 Asia Pacific Nuclear Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
165 Asia Pacific Nuclear Medicine Market Outlook, By Diagnostic Centers (2013-2022) ($MN)
166 Asia Pacific Nuclear Medicine Market Outlook, By Stable Isotope (2013-2022) ($MN)
167 Asia Pacific Nuclear Medicine Market Outlook, By Sulphur (S-32) (2013-2022) ($MN)
168 Asia Pacific Nuclear Medicine Market Outlook, By Oxygen (O-18) (2013-2022) ($MN)
169 Asia Pacific Nuclear Medicine Market Outlook, By Nitrogen (N-15) (2013-2022) ($MN)
170 Asia Pacific Nuclear Medicine Market Outlook, By Deuterium (D2) (2013-2022) ($MN)
171 Asia Pacific Nuclear Medicine Market Outlook, By Carbon (C-13) (2013-2022) ($MN)
172 Asia Pacific Nuclear Medicine Market Outlook, By Other stable isotopes (2013-2022) ($MN)
173 RoW Nuclear Medicine Market Outlook, By Country (2013-2022) ($MN)
174 RoW Nuclear Medicine Market Outlook, By Application (2013-2022) ($MN)
175 RoW Nuclear Medicine Market Outlook, By Therapeutics (2013-2022) ($MN)
176 RoW Nuclear Medicine Market Outlook, By Bone Metastasis (2013-2022) ($MN)
177 RoW Nuclear Medicine Market Outlook, By Endocrine Tumors (2013-2022) ($MN)
178 RoW Nuclear Medicine Market Outlook, By Lymphoma (2013-2022) ($MN)
179 RoW Nuclear Medicine Market Outlook, By Thyroid (2013-2022) ($MN)
180 RoW Nuclear Medicine Market Outlook, By Nephrology (2013-2022) ($MN)
181 RoW Nuclear Medicine Market Outlook, By Cardiology (2013-2022) ($MN)
182 RoW Nuclear Medicine Market Outlook, By Neurology (2013-2022) ($MN)
183 RoW Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
184 RoW Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
185 RoW Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
186 RoW Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
187 RoW Nuclear Medicine Market Outlook, By Type (2013-2022) ($MN)
188 RoW Nuclear Medicine Market Outlook, By Nuclear Medicine Therapeutic Isotopes (2013-2022) ($MN)
189 RoW Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
190 RoW Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
191 RoW Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
192 RoW Nuclear Medicine Market Outlook, By Nuclear Medicine/Radiopharmaceuticals Diagnostics (2013-2022) ($MN)
193 RoW Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
194 RoW Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
195 RoW Nuclear Medicine Market Outlook, By Procedural Volume (2013-2022) ($MN)
196 RoW Nuclear Medicine Market Outlook, By Therapeutic (2013-2022) ($MN)
197 RoW Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
198 RoW Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
199 RoW Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
200 RoW Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
201 RoW Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2013-2022) ($MN)
202 RoW Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
203 RoW Nuclear Medicine Market Outlook, By End User (2013-2022) ($MN)
204 RoW Nuclear Medicine Market Outlook, By Academic Research Laboratories (2013-2022) ($MN)
205 RoW Nuclear Medicine Market Outlook, By Industries (2013-2022) ($MN)
206 RoW Nuclear Medicine Market Outlook, By Medical (2013-2022) ($MN)
207 RoW Nuclear Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
208 RoW Nuclear Medicine Market Outlook, By Diagnostic Centers (2013-2022) ($MN)
209 RoW Nuclear Medicine Market Outlook, By Stable Isotope (2013-2022) ($MN)
210 RoW Nuclear Medicine Market Outlook, By Sulphur (S-32) (2013-2022) ($MN)
211 RoW Nuclear Medicine Market Outlook, By Oxygen (O-18) (2013-2022) ($MN)
212 RoW Nuclear Medicine Market Outlook, By Nitrogen (N-15) (2013-2022) ($MN)
213 RoW Nuclear Medicine Market Outlook, By Deuterium (D2) (2013-2022) ($MN)
214 RoW Nuclear Medicine Market Outlook, By Carbon (C-13) (2013-2022) ($MN)
215 RoW Nuclear Medicine Market Outlook, By Other stable isotopes (2013-2022) ($MN)


【レポート販売概要】

■ タイトル:核医学の世界市場2015-2022
■ 英文:Nuclear Medicine - Global Market Outlook (2015-2022)
■ 発行日:2016年6月19日
■ 調査会社:Stratistics MRC
■ 商品コード:SMRC60765
■ 調査対象地域:グローバル
  • チェーンドライブの世界市場2015-2019
    About Chain Drives Chain drives and belt drives are the mechanical power transmission systems used for transmitting energy to perform valuable work in industries. These drives consist of interconnected links meshing with the teeth of a sprocket. There are various types of chain drives, including roller chains and engineering steel chains. Engineering steel chains are used for applications in indus …
  • エポキシ樹脂の世界市場分析:用途別(塗料・コーティング、風力タービン、複合材料、建設、電気・電子、接着剤)、セグメント予測
    The global epoxy resin market is expected to reach USD 14.26 billion by 2024, according to a new report by Grand View Research, Inc. The market is anticipated to be driven by end-use industries including automotive, aerospace, transportation, composites, decorative coatings, construction, industrial & marine coatings, electrical & electronics, especially in Asia Pacific. Epoxy resins are the most …
  • 自動車用エレクトロニクスの世界市場:コンポーネント別(ECU、通電デバイス、センサー)、アプリケーション別(安全システム、ADAS、ボディエレクトロニクス)、販売チャネル別、セグメント予測
    The global automotive electronics market size is expected to reach USD 410.13 billion by 2025 at a CAGR of 8.7% over the forecast period, according to a study conducted by Grand View Research, Inc. Stringent government regulations regarding fuel emission standards along with growing inclusion of road safety systems and demand for state-of-the-art vehicles are anticipated to drive the market. Techn …
  • 画像診断装置の世界市場予測(~2021年):X線装置、MRI装置、超音波装置、CT、SPECT、ハイブリッドPET
    The global diagnostic imaging market is estimated to grow at a CAGR of 6.6% from 2016 to 2021 to reach USD 36.43 billion by 2021. Factors such as increasing prevalence of chronic diseases, rapid growth in the geriatric population, growing government investments for modernization of imaging facilities, rising number of private imaging centers (especially in emerging countries), technological advanc …
  • BIPV(建材一体型太陽光発電)の世界市場2015-2019
    About BIPV BIPV are PV materials that are used in place of conventional building materials as an auxiliary source for power. BIPV integrates solar energy with that of building design. They are used in various parts of building envelops such as roofs, facades, and skylights. BIPV technology can be incorporated either during the construction of a new building or it can be retrofitted to an old build …
  • Medivators Inc.:市場シェア分析
    Medivators Inc. Market Share Analysis Summary GlobalData’s new report, “Medivators Inc. Market Share Analysis” provides in-depth information on Medivators Inc.’s market position in the different medical equipment markets it operates in. The report provides Medivators Inc. market share information in one key market categories – Endoscopic Reprocessors. The report also provides data and information …
  • Cryptococcosis:グローバル臨床試験レビューH1, 2013
    Cryptococcosis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Cryptococcosis Global Clinical Trials Review, H1, 2013" provides data on the Cryptococcosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptococcosis. It includes an overview of the trial numbers and their recruitment status as per …
  • コンフェクショナリーの世界市場:チョコレート、砂糖菓子、ガム
    About Confectionery Confectionery comprises of chocolate, sugar confectionery, and gum. Cocoa and sugar are the raw materials for chocolate and latex is the raw material used for gum. Many new varieties of confectionery products have been introduced in the market. Confectionery products are popular among all age groups of people. Further, the sale of confectionery product is not dependent on any s …
  • 膜型バイオリアクターの世界市場:フラットシート(FS)MBR、チューブ状(TB)MBR
    About Membrane Bioreactor MBR is a process that combines membrane filtration with biological treatment. An MBR system is an advanced version of CAS system. MBR finds various applications in the Wastewater Treatment industry as it assists in the separation of algae, bacteria, and suspended particles from wastewater. TechNavio's analysts forecast the Global MBR market to grow at a CAGR of 15.21 perc …
  • 産業用エネルギー管理システムの世界市場:エネルギー管理ソフトウェア/装置/サービス
    About Energy Management System in Industrial Sector Energy management system for the Industrial sector is a system of computer-aided tools that help industries to monitor, control, and optimize their electrical loads. Energy management trend is shifting from hardware-based solutions to extensive software, hardware, and service-based solutions. This is achieved through a holistic view into the ener …
  • グリーン・キレート剤の世界市場2017-2021
    About Green Chelating Agents Chelating agents are substances that remove ions from a solution system, without reacting with it. They are also known as sequestering agents or complexing agents. Chelating agents are used as scale inhibitors and in cleaning products. The agents bind to ions of calcium, magnesium, iron, and other metals. The result of using chelating agents is to increase the cleaning …
  • アジピン酸(ADPA)の世界市場予測
    Adipic acid: 2014 World Market Outlook and Forecast' is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about adipic acid market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical part …
  • 熱成形プラスチックの世界市場2019-2023
    About this market The growing demand for thermoformed plastics from the food packaging industry is one of the critical reasons that will drive the thermoformed plastics market. Thermoformed plastics are not only used to manufacture trays, cups, clamshells, and containers but also tri-fold packs and blister packs. These plastics are manufactured using polystyrene, PET, and polypropylene. The global …
  • ブラインの世界市場
    The report covers the analysis of the global brine market on the basis of applications and geography. The market data for these types is given with respect to volume (kilotons) and value ($million). The market of brine was estimated to be approximately $780 million in 2014 and is projected to witness a CAGR of 5% between 2014 and 2019. The data mentioned in the report is based on the global demand …
  • 世界の気道装置・麻酔装置開発動向:医療機器パイプライン分析2015
    Airway and Anesthesia Devices - Medical Devices Pipeline Assessment, 2015 Summary GlobalData's Medical Devices sector report, “Airway and Anesthesia Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Airway and Anesthesia Devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。